Hologic Inc - Asset Resilience Ratio
Hologic Inc (HOLX) has an Asset Resilience Ratio of 2.14% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Hologic Inc for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1996–2025)
This chart shows how Hologic Inc's Asset Resilience Ratio has changed over time. See Hologic Inc (HOLX) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Hologic Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hologic Inc market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $196.70 Million | 2.14% |
| Total Liquid Assets | $196.70 Million | 2.14% |
Asset Resilience Insights
- Limited Liquidity: Hologic Inc maintains only 2.14% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hologic Inc Industry Peers by Asset Resilience Ratio
Compare Hologic Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Visco Vision Inc.
TW:6782 |
Medical Instruments & Supplies | 0.98% |
|
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026 |
Medical Instruments & Supplies | 2.86% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
Annual Asset Resilience Ratio for Hologic Inc (1996–2025)
The table below shows the annual Asset Resilience Ratio data for Hologic Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-09-30 | 2.70% | $243.20 Million | $9.01 Billion | +0.80pp |
| 2024-09-30 | 1.89% | $173.40 Million | $9.16 Billion | +1.72pp |
| 2023-09-30 | 0.18% | $16.20 Million | $9.14 Billion | -0.17pp |
| 2022-09-30 | 0.35% | $31.90 Million | $9.07 Billion | +0.35pp |
| 2019-09-30 | 0.00% | $100.00K | $6.61 Billion | -0.08pp |
| 2018-09-30 | 0.08% | $6.00 Million | $7.23 Billion | +0.04pp |
| 2017-09-30 | 0.05% | $3.60 Million | $7.98 Billion | +0.03pp |
| 2016-09-30 | 0.01% | $1.00 Million | $7.32 Billion | +0.00pp |
| 2015-09-30 | 0.01% | $700.00K | $7.67 Billion | -0.06pp |
| 2014-09-30 | 0.07% | $5.50 Million | $8.41 Billion | -0.01pp |
| 2013-09-30 | 0.08% | $6.91 Million | $9.00 Billion | +0.02pp |
| 2012-09-30 | 0.05% | $5.70 Million | $10.48 Billion | +0.05pp |
| 2011-09-30 | 0.01% | $537.00K | $6.01 Billion | -0.01pp |
| 2010-09-30 | 0.02% | $942.00K | $5.63 Billion | +0.00pp |
| 2009-09-30 | 0.02% | $916.00K | $5.69 Billion | -0.03pp |
| 2008-09-30 | 0.04% | $3.63 Million | $8.13 Billion | -14.86pp |
| 1999-09-30 | 14.90% | $26.20 Million | $175.80 Million | -0.74pp |
| 1998-09-30 | 15.64% | $27.00 Million | $172.60 Million | -23.06pp |
| 1997-09-30 | 38.70% | $56.00 Million | $144.70 Million | +0.52pp |
| 1996-09-30 | 38.18% | $47.00 Million | $123.10 Million | -- |
About Hologic Inc
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms… Read more